Shuji Kitahara

8PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Comparative and cross-cultural educationCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 29, 2025
Correction: Onodera et al. Prognostic Factors and Talaporfin Sodium Concentration in Photodynamic Therapy for Recurrent Grade 4 Glioma. Pharmaceuticals 2025, 18, 583.

Mikoto Onodera, Shuji Kitahara, Yasuto Sato

|Apr 26, 2025
Prognostic Factors and Talaporfin Sodium Concentration in Photodynamic Therapy for Recurrent Grade 4 Glioma.

Mikoto Onodera, Shuji Kitahara, Yasuto Sato

|Jan 27, 2025
HIFU induces reprogramming of the tumor immune microenvironment in a pancreatic cancer mouse model.

Toshihiro Yamaguchi, Shuji Kitahara, Aya Matsui

|Aug 14, 2023
A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment.

Dan Duda, Simona Dima, Andrei Sorop

|Feb 25, 2023
Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models.

Nisha Gupta, Hiroki Ochiai, Yoshinori Hoshino

|Dec 24, 2021
Current Landscape of Sonodynamic Therapy for Treating Cancer.

Toshihiro Yamaguchi, Shuji Kitahara, Kaori Kusuda

Pageof 2

Frequent Collaborators

2 joint publications

Yoshihiro Muragaki

2 joint publications

Takakazu Kawamata

2 joint publications

Yasuto Sato

2 joint publications

Dan G Duda